fentanyl and bupivacaine
Phase 3Small molecule
fentanyl and bupivacaine is one of 71 small molecule programs targeting Cesarean Section. It is currently in Phase 3.
2
Indications
5
Total Trials
1
Active Trials
70
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
83 competitors in Cesarean Section
#DrugCompanyPhaseTrials
1Fentanyl-Morphine
SSeoul National University Hospital
Phase 3
fentanyl and bupivacaine
HHospital Central Dr. Luis Ortega
Phase 3
Ondansetron, Dexamethasone
KKing Khaled Eye Specialist Hospital
Phase 3
Acetaminophen/ibuprofen
SSeoul National University Hospital
Phase 3
Morphine - .
RRambam Health Care Campus
Phase 3
Sebacoyl Dinalbuphine Ester
LLumosa Therapeutics Co., Ltd.
Phase 3
Dynastat
PfizerPreclinical
Proamatine
TakedaPreclinical
Duragesic
CCephalon
Preclinical
Versed
CConrado Roberto Hoffmann Filho
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Hyperbaric Bupivacaine1 trial
Bupivacaine1 trial
Effect of Fentanyl With Topical Levobupivacaine With Nasal Packing in Endoscopic Nasal Surgery
Unknown status·—·Phase 2·NCT04410588·75 enrolled
Cesarean Section1 trial
Postoperative Analgesia1 trial
Comparative Study Between Intrathecal Magnesium Sulfate, Neostigmine and Fentanyl As Adjuvant for Bubivacaine in Postoperative Analgesia in Lower Abdominal Surgeries
Not yet recruiting·—·Phase 4·NCT06685705·66 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for fentanyl and bupivacaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- HHospital Central Dr. Luis Ortega